Innovations in Pharmaceutical Sciences & Care

Background: Headache is a widespread neurological condition in the world with a massive impact on daily functioning, productivity, and quality of life. The major subtypes of headaches, such as tension-type and migraine, display different levels and are usually triggered by stress, sleep deprivation, and environmental conditions. Paracetamol happens to be one of the most common analgesics to relieve acute headaches since it is safe and readily available. Purpose: The purpose of the study was to determine the effectiveness of a single 500 mg dose of paracetamol in lowering the severity of headaches in the Australian community. Methods: A pre-and and post-quasi-experimental design was used on 385 adults with mild to moderate headaches. A 0-10 Numeric Rating Scale was used to measure the severity of headaches prior to and an hour after the administration of paracetamol. Socio-demographic, health, and lifestyle factors were also measured. Descriptive statistics and paired sample t-test were used to analyze data. Results: At pre-intervention, 26.9% of study participants had moderately severe pain (score 6), 24.4% severe pain (score 7), and 14.8% moderate pain (score 5). After intervention, 8.3% had no pain (score 0), 14.5% had very mild pain (score 1), and 20.2% had mild pain (score 2). Paired t-test revealed that there was a significant decrease in the severity of pain (mean difference = 2.987, SD = 0.631, 95% CI: 2.924-3.050, t = 92.871, p < 0.001). Conclusion: The severity of the headache can be effectively reduced through timely analgesic intervention, resulting in rapid and measurable improvement in pain intensity in adult populations.